Universität Wien

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2017W)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung

Details

Sprache: Englisch

Lehrende

Termine

2017-10-02, 14.00h-17:00h: UZA2 2D313
2017-10-03, 14.00h-17:00h: UZA2 2D313
2017-10-04, 14.00h-17:00h: UZA2 2D358
2017-10-05, 14.00h-17:00h: UZA2 2D313
2017-10-10, 14.00h-17:00h: UZA2 2D313
2017-10-11, 14.00h-17:00h: UZA2 2D358
2017-10-12, 14.00h-17:00h: UZA2 2D313
2017-10-13, 14.00h-17:00h: UZA2 2D411
2017-10-17, 14.00h-17:00h: UZA2 2D313
2017-10-18, 14.00h-17:00h: UZA2 2D358
2017-10-19, 14.00h-17:00h: UZA2 2D313
2017-10-22, 14.00h-17:00h: UZA2 2D313


Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

There will be one written exam at the end of the course.
The grades will be deduced to 40% from the result in the written exam, to 30% from the quality of the oral presentations and 30 % from the active participation in the discussions during the course.

Mindestanforderungen und Beurteilungsmaßstab

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.

Prüfungsstoff

All topics covered during the course.

Literatur

Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Fr 31.08.2018 08:43